These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15571000)

  • 1. Therapies for hepatic fibrosis: real hope or just academic exercise?
    Pinzani M
    Dig Liver Dis; 2004 Nov; 36(11):714-6. PubMed ID: 15571000
    [No Abstract]   [Full Text] [Related]  

  • 2. The global impact of hepatic fibrosis and end-stage liver disease.
    Lim YS; Kim WR
    Clin Liver Dis; 2008 Nov; 12(4):733-46, vii. PubMed ID: 18984463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversibility of hepatic fibrosis and cirrhosis--is it all hype?
    Friedman SL
    Nat Clin Pract Gastroenterol Hepatol; 2007 May; 4(5):236-7. PubMed ID: 17476207
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prospect of liver fibrosis].
    Jia JD
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):5-6. PubMed ID: 19391279
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of lipoic acid and its amide in chronic liver diseases].
    Romanov VS
    Sov Med; 1971; 34(12):43-5. PubMed ID: 4948129
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of liver cirrhosis and chronic liver diseases with total liver extract].
    Borgo E
    Minerva Med; 1965 Nov; 56(88):3735-9. PubMed ID: 5846626
    [No Abstract]   [Full Text] [Related]  

  • 7. [Silymarin and various problems of current therapy of chronic liver diseases].
    Fassati P; Fassati M
    Cas Lek Cesk; 1973; 112(28):865-9. PubMed ID: 4720441
    [No Abstract]   [Full Text] [Related]  

  • 8. [Our experience with long-term therapy of chronic liver diseases using Superanabolon Spofa].
    Svacinka P; Horký J; Blahníková L
    Vnitr Lek; 1970 Dec; 16(12):1181-7. PubMed ID: 5491517
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug therapy of chronic inflammatory liver diseases].
    Vetter K; Kettler LH; Kaschube I; Lüder W
    Dtsch Z Verdau Stoffwechselkr; 1966 Dec; 26(3):121-9. PubMed ID: 5998373
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug insight: the role of albumin in the management of chronic liver disease.
    Wong F
    Nat Clin Pract Gastroenterol Hepatol; 2007 Jan; 4(1):43-51. PubMed ID: 17203088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Safe prescribing in patients with liver cirrhosis; 5 pitfalls].
    Weersink RA; Drenth JPH; Ter Borg F; Mulder MB; Taxis K; Borgsteede SD
    Ned Tijdschr Geneeskd; 2020 Oct; 164():. PubMed ID: 33201633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical application of non-invasive diagnosis for hepatic fibrosis].
    Cho SW; Cheong JY
    Korean J Hepatol; 2007 Jun; 13(2):129-37. PubMed ID: 17585186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent findings in drug treatment of liver disease patients with ornithine-carbamyl-transferase (OCT). Personal experience].
    Alvisi V; Tralli M; Tampieri ML; Lo Ponte A; D'Ambrosi A
    Minerva Dietol Gastroenterol; 1982; 28(4):335-40. PubMed ID: 7167246
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition.
    Svegliati-Baroni G; De Minicis S; Marzioni M
    Liver Int; 2008 Sep; 28(8):1052-64. PubMed ID: 18783548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial.
    Everson GT; Shiffman ML; Morgan TR; Hoefs JC; Sterling RK; Wagner DA; Kulig CC; Curto TM; Wright EC;
    Aliment Pharmacol Ther; 2008 May; 27(9):798-809. PubMed ID: 18266997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.
    Karimian G; Mohammadi-Karakani A; Sotoudeh M; Ghazi-Khansari M; Ghobadi G; Shakiba B
    Biomed Pharmacother; 2008 Jun; 62(5):312-6. PubMed ID: 18191530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
    Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.
    Friedman SL
    Nat Clin Pract Gastroenterol Hepatol; 2004 Dec; 1(2):98-105. PubMed ID: 16265071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatobiliary and pancreatic: cirrhosis secondary to hepatic sarcoidosis.
    Malhotra A; Naniwadekar A; Sood G
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1942. PubMed ID: 19120880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.